PL412005A1 - Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III) - Google Patents
Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III)Info
- Publication number
- PL412005A1 PL412005A1 PL412005A PL41200515A PL412005A1 PL 412005 A1 PL412005 A1 PL 412005A1 PL 412005 A PL412005 A PL 412005A PL 41200515 A PL41200515 A PL 41200515A PL 412005 A1 PL412005 A1 PL 412005A1
- Authority
- PL
- Poland
- Prior art keywords
- soluble
- iii
- water
- gold complexes
- intelligent
- Prior art date
Links
Abstract
Ujawniono wodorozpuszczalne, inteligentne kompleksy złota (III) o ogólnym wzorze 1: [Au(CN)m]n(m-p)n ,gdzie m ma wartość od 3 do 6, n ma wartość od 1 do 10, p ma wartość od 1 do 3. Zastosowanie wodorozpuszczalnych, inteligentnych kompleksów złota (III) o wzorze ogólnym 1 w postaci pojedynczego leku lub środka farmaceutycznego, lub suplementu diety, lub dodatku do żywności w terapeutycznie uzasadnionej ilości i dowolnym sposobie podawania.Water-soluble intelligent gold (III) complexes with general formula 1 are disclosed: [Au (CN) m] n (mp) n, where m is from 3 to 6, n is from 1 to 10, p is from 1 to 10 3. Use of water-soluble intelligent gold (III) complexes of general formula 1 in the form of a single drug or pharmaceutical agent, or dietary supplement, or food additive in a therapeutically justified amount and in any method of administration.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL412005A PL232677B1 (en) | 2015-04-15 | 2015-04-15 | Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL412005A PL232677B1 (en) | 2015-04-15 | 2015-04-15 | Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL412005A1 true PL412005A1 (en) | 2016-10-24 |
| PL232677B1 PL232677B1 (en) | 2019-07-31 |
Family
ID=57821648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL412005A PL232677B1 (en) | 2015-04-15 | 2015-04-15 | Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III) |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL232677B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019008013A1 (en) | 2017-07-04 | 2019-01-10 | Szczepaniak Stanislaw | Water-soluble gold (iii) complexes, methods of producing water-soluble gold (iii) complexes and their use |
-
2015
- 2015-04-15 PL PL412005A patent/PL232677B1/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019008013A1 (en) | 2017-07-04 | 2019-01-10 | Szczepaniak Stanislaw | Water-soluble gold (iii) complexes, methods of producing water-soluble gold (iii) complexes and their use |
| PL422125A1 (en) * | 2017-07-04 | 2019-01-14 | Stanisław Szczepaniak | Water-soluble intelligent gold complexes (III), method for producing water-soluble intelligent gold complexes (III) and their application |
Also Published As
| Publication number | Publication date |
|---|---|
| PL232677B1 (en) | 2019-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202007143B (en) | Pyridone derivative, composition thereof and application thereof as anti-influenza drug | |
| MX2016010533A (en) | Anti-her3 antibody-drug conjugate. | |
| PH12019501811A1 (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| PH12017500481A1 (en) | Novel soluble guanylate cyclase activators and their use | |
| EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
| MD3482754T2 (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
| MX2019004579A (en) | Oral care compositions and methods of use. | |
| PH12020500074A1 (en) | Peptide | |
| EA201692270A1 (en) | DERIVATIVES OF NAFTYRIDINDIONE | |
| MX2019006107A (en) | Arsenic compositions. | |
| PL412005A1 (en) | Water-soluble intelligent gold complexes (III) and application of water-soluble, intelligent gold complexes (III) | |
| NZ757526A (en) | Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction | |
| NZ712584A (en) | Antitumor agent including irinotecan hydrochloride hydrate | |
| MX2015017881A (en) | Method for preventing and/or treating chronic traumatic encephalopathy-ii. | |
| PL428118A1 (en) | Complex organic silicon compounds, method of preparing complex organic silicon compounds and use of complex organic silicon compounds | |
| RU2014107146A (en) | METHOD FOR PREVENTING A CARCINOGENIC EFFECT OF DIETHYLNITROSAMINE IN EXPERIMENTAL ANIMALS | |
| UA120079C2 (en) | APPLICATION OF 2-SUBSTITUTED 5-ARYLSULPHONYL-1,3-OXAZOLE-4-CARBONITRILLES AS ANTI-CANCER DRUGS | |
| PL409503A1 (en) | Dietary supplement and therapeutic mixture | |
| CN106490706A (en) | Length Combined trouserses | |
| PL425238A1 (en) | Application of 2'-hydroxy-4-ethylchalcone | |
| PL425239A1 (en) | Application of 2'-hydroxy-4-methylchalcone | |
| UA129564U (en) | METHOD OF COMPLEX PREVENTION OF VITAMIN D DEFICIENCY AFFECTING CALCULATION, MAGNESIUM, ZINC IN PREGNANT WOMEN | |
| Yiyi | President Li Xiaolin Leads CPAFFC Delegation to Thailand | |
| PL415332A1 (en) | Composition of a dietary medium | |
| TH174172B (en) | pants |